Skip to main content

CASI Pharmaceuticals, Inc (DE)

CASIDelisted
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000895051

CASI Pharmaceuticals, Inc (DE) was delisted in 2023; its insiders filed their last Form 4 on Sep 9, 2022; 23 institutions reported holding it in 13F filings for Q4 2022, worth $3.31M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding CASI Pharmaceuticals, Inc (DE) changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of CASI: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders4524−21
SharesConverted for a 1-for-10 split2.33M2.19M−144.4K (−6.2%)
Value$18.9M$6.26M−$12.6M (−66.9%)

New holders (1)

Institutions that held CASI Pharmaceuticals, Inc (DE) at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to CASI in Q2 2022
InstitutionSharesValue% of portfolio
Credit Suisse AG2,797$8.00K0.00%

Sold out (22)

Institutions that held CASI Pharmaceuticals, Inc (DE) at the end of Q1 2022 and filed for Q2 2022 without it.